Wednesday, June 26, 2013

Aspirin May Fight Cancer by Slowing DNA Damage

›
Researchers hypothesized that NSAIDs modulate clonal evolution by reducing SGA acquisition rate. Researchers  evaluated thirteen individua...

FDA Approves Vibativ for Hospitalized Patients with Bacterial Pneumonia

›
We know that, Telavancin (trade name Vibativ) is a bactericidal lipoglycopeptide for use in MRSA or other Gram-positive infections. Telava...
Wednesday, June 19, 2013

Diabetes drug points the way to overcoming drug resistance in melanoma

›
Despite success with BRAFV600E inhibitors, therapeutic responses in patients with metastatic melanoma are short-lived because of the acq...
Tuesday, June 18, 2013

Diabetes drug shows promise in treatment of neurodegenerative disease

›
In continuation of my update on  Pioglitazone We know that ,  Pioglitazone  is a prescription drug of the class  thiazolidinedione ...
Monday, June 17, 2013

Flamel Technologies Announces FDA Approval of Bloxiverz

›
Flamel Technologies today announced that the U.S. Food and Drug Administration (FDA) has approved the company's New Drug Application (...
Friday, June 14, 2013

Small molecule could have big impact on cancer

›
Androgen receptors are found inside cells and have complex surfaces with multiple "docking points" where various proteins can...
Thursday, June 13, 2013

FDA Approves Revlimid (lenalidomide) for the Treatment of Patients with Relapsed or Refractory Mantle Cell Lymphoma

›
In continuation of my update on Lenalidomide We know that, Lenalidomide  ( Revlimid ) is a derivative of thalidomide introduced in ...
Wednesday, June 12, 2013

FDA Approves TOBI Podhaler

›
We know that, Tobramycin is an aminoglycoside antibiotic derived from Streptomyces tenebrarius and used to treat various types of bacter...
Tuesday, June 11, 2013

Bristol-Myers Squibb Receives US FDA sNDA Approval for Use of SUSTIVA® (efavirenz) in HIV-1 Infected Pediatric Patients | BMS Newsroom

›
We know that, Efavirenz (EFV, brand names Sustiva , Stocrin , Efavir etc.) is a non-nucleoside reverse transcriptase inhibitor (NNRTI) ...
Monday, June 10, 2013

FDA Approves Tafinlar (dabrafenib) for Advanced Melanoma

›
In conyinaution of my update on Dabrafenib   GlaxoSmithKline plc announced today that the U.S. Food and Drug Administration (FDA...
Friday, June 7, 2013

FDA Approves Mekinist (trametinib) for Advanced Melanoma

›
In continuation of my update on Trametinib   GlaxoSmithKline plc announced today that the U.S. Food and Drug Administration (FDA...
Thursday, June 6, 2013

Cancer Fighting Foods.............

›
Cancer Fighting Foods: How can food fight cancer, you ask? In many, many ways! Certain healthy foods can lower your risk for ...
1 comment:
Tuesday, June 4, 2013

Raptor Pharmaceutical's PROCYSBI™ Receives FDA Approval for the Treatment of Nephropathic Cystinosis

›
Cysteamine bitartrate,  is a cystine depleting agent which lowers the cystine content of cells in patients with cystinosis, an inherite...
Monday, June 3, 2013

Arbor Pharmaceuticals Announces FDA Approval of Nymalize

›
We know that, Nimodipine (marketed by Bayer as Nimotop ) is a dihydropyridine calcium channel blocker originally developed for the treatm...
Sunday, June 2, 2013

First drug to significantly improve heart failure mortality in over a decade

›
We know that , Coenzyme Q 10 , also known as ubiquinone , ubidecarenone , coenzyme Q , and abbreviated at times to CoQ 10 , CoQ , or Q...